Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis · Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Shayna Pehel) · Shayna.Pehel@nyulangone.org · 929-455-5104

Study leads

Leigh Charvet, PhD
Principal Investigator
NYU Langone Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Bihać, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Multiple Sclerosis · Sleep · Pain

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS)

Abroad (travel likely)RecruitingPHASE2

Giza, Egypt